Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer

Wang, ML; Chen, XL; Tan, P; Wang, YY; Pan, XY; Lin, TH; Jiang, Y; Wang, B; Xu, H; Wang, YY; Yang, YC; Wang, J; Zhao, L; Zhang, JP; Zhong, AL; Peng, YM; Du, JJ; Zhang, Q; Zheng, JA; Chen, JY; Dai, SQ; Na, FF; Lu, ZH; Liu, JM; Zheng, XA; Yang, L; Zhang, P; Han, P; Gong, QY; Zhong, Q; Xiao, K; Yang, HS; Deng, HX; Zhao, YL; Shi, HB; Man, JH; Gou, ML; Zhao, CJ; Dai, LZ; Xue, ZH; Chen, L; Wang, Y; Zeng, MS; Huang, CH; Wei, Q; Wei, YQ; Liu, Y; Chen, C

Wei, Q; Chen, C (通讯作者),Sichuan Univ, Inst Urol, Dept Urol, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.;Wei, Q; Chen, C (通讯作者),Sichuan Univ, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.;Liu, Y (通讯作者),Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.;Liu, Y (通讯作者),Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.

CANCER CELL, 2022; 40 (9): 1044

Abstract

Cisplatin-based chemotherapy remains the primary treatment for unresectable and metastatic muscle -inva-sive bladder cancers (MIBCs). However, tumors ......

Full Text Link